Sign In
Buy BAX
$27.78
+0.230 (+0.83%)
At Close: Aug 10, 2026
Tracking Al Gore's Generation Investment Management Portfolio - Q2 2020 Update
12:15pm, Wednesday, 09'th Sep 2020
Generation Investment Management’s 13F portfolio value increased from $14.09B to $17.34B this quarter.
Baxter Is Largely Defensive: Hide In Baxter, But Don't Speculate
09:36am, Wednesday, 09'th Sep 2020
BAX has a solid product line and impressive pricing power, but large operations and development risks to match.
Tracking Larry Robbins' Glenview Capital Management Portfolio - Q2 2020 Update
03:50pm, Friday, 04'th Sep 2020
Glenview Capital Management's 13F portfolio value decreased from $3.68B to $3.63B this quarter. The number of positions decreased from 44 to 43.
Bullish On Baxter: Cruising Along, Business As Usual; $90 Price Target Set
12:09pm, Friday, 28'th Aug 2020
Baxter continues to chug on slowly as it has done for the past 10 years, delivering ongoing value to shareholders.
Tracking Dan Loeb's Third Point Portfolio - Q2 2020 Update
09:36am, Friday, 28'th Aug 2020
Dan Loeb's 13F portfolio value increased from $6.27B to $7.30B this quarter. The number of positions increased from 30 to 36.
Outset Medical Begins U.S. IPO Rollout
03:24pm, Monday, 24'th Aug 2020
Outset Medical has filed to raise $100 million in an IPO, although the final figure may differ. The firm is commercializing an improved hemodialysis machine.
Daniel Loeb's Top 6 Trades in the 2nd Quarter
10:49pm, Wednesday, 19'th Aug 2020
Activist investor reduces top-holding Baxter, buys 2 Chinese retail stocks
Baxter to Present at the 2020 Wells Fargo Virtual Healthcare Conference
08:15pm, Wednesday, 19'th Aug 2020
Baxter International Inc. (NYSE:BAX), a leading global medical products company, will present at the 2020 Wells Fargo Virtual Healthcare Conference via webcast on Wednesday, September 9, 2020. Jay Sac
BMEZ: Continuing To Weather The Pandemic Storm
11:38am, Wednesday, 19'th Aug 2020
BMEZ is a fund that is focused on the healthcare space, more specifically, a focus on the health sciences industry.
Baxter (BAX) Receives EUA for Regiocit Replacement Solution
10:06am, Monday, 17'th Aug 2020
Baxter (BAX) receives EUA from the FDA for Regiocit, which is the only authorized citrate-based replacement solution for use in CRRT during the COVID-19 pandemic.
Baxter Gets FDA Emergency Use Nod For Regiocit During Covid-19 Pandemic
06:34am, Sunday, 16'th Aug 2020
Baxter International has been granted Emergency Use Authorization (EUA) by the US Food and Drug Administration (FDA) for its Regiocit, to be used during the coronavirus pandemic as a replacement solu
Baxter Obtains U.S. FDA Emergency Use Authorization for Regiocit Replacement Solution Used in CRRT
09:00pm, Friday, 14'th Aug 2020
Baxter International Inc. (NYSE:BAX), a global leader in acute care, announced it has received Emergency Use Authorization (EUA) from the U.S. Food and Drug Administration (FDA) for Regiocit, the comp
Tracking Tweedy Browne Portfolio - Q2 2020 Update
11:03pm, Wednesday, 12'th Aug 2020
Tweedy Browne’s 13F portfolio value increased from $2.15B to $2.51B this quarter. The largest five individual stock positions are Alphabet, Berkshire Hathaway, Johnson & Johnson, Cisco Systems, and
Baxter Obtains U.S. FDA Emergency Use Authorizations for HF20 Set and ST Set Used in CRRT During Covid-19 Pandemic
01:00pm, Wednesday, 12'th Aug 2020
Baxter International Inc. (NYSE:BAX), a global leader in acute care, announced it has received Emergency Use Authorizations (EUAs) from the U.S. Food and Drug Administration (FDA) for the company’s
Global Chemotherapy-induced Nausea and Vomiting Drugs Market 2020-2024: Anticipated to Grow by $525 Million - ResearchAndMarkets.com
12:00am, Tuesday, 11'th Aug 2020
The
